ERLANGER, KY / ACCESSWIRE / March 12, 2024 / The Holland Foundation for Sight Restoration is proud to announce, “Eye Love Rock N’ Roll,” a benefit concert taking place at 8 p.m. on Sunday, April 7, 2024, at The Sinclair in Cambridge. The event will coincide with the American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting in Boston and aims to raise funds for the Foundation’s mission of restoring sight to those in need.
The Holland Foundation for Sight Restoration is a non-profit organization dedicated to addressing the significant unmet medical need of corneal transplantation for patients who have Severe Ocular Surface Disease and is the only foundation in the world providing resources to surgeons and patients to improve access and availability for this advanced care.
“We are thrilled to host ‘Eye Love Rock N’ Roll’ in Boston 2024,” said Kila Hanrahan, Director of Development of the Holland Foundation for Sight Restoration. “This event is not only a celebration of music but also a celebration of sight and the incredible impact it has on our lives. We are grateful for the opportunity to raise awareness and support for our mission.”
The concert will feature performances by ophthalmologists and industry partners, with special guests The Hoodies and the Queen Masterstroke Tribute Band, creating an unforgettable evening of music and philanthropy. Attendees will have the chance to enjoy live music while supporting a noble cause, with all proceeds from the event going directly to the Holland Foundation for Sight Restoration.
Tickets for “Eye Love Rock N’ Roll” are now available for purchase online at the event website. Don’t miss this opportunity to experience great music and make a difference in the lives of those in need. Join us on April 7th for an evening of rock n’ roll and philanthropy!
For more information about the Holland Foundation for Sight Restoration and its mission, please visit hollandfoundationforsight.org.
Contact Information
Kila Hanrahan
Director of Development
kila@hollandfoundationforsight.org
(859) 409-0009
SOURCE: Holland Foundation for Sight Restoration
View the original press release on newswire.com.
PARSORTIX HER2 ASSAY SHOWCASED AT PRESTIGIOUS INTERNATIONAL CANCER CONFERENCECTC HER2 assay being developed for HER2…
Toronto, Ontario--(Newsfile Corp. - April 7, 2024) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE)…
SHANGHAI, China, April 07, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”,…
V-INITIATE trial demonstrates that early initiation with Leqvio, prior to guideline-recommended ezetimibe, for ASCVD patients…
-- Findings Presented on VASCEPA/VAZKEPA Utility in REDUCE-IT Patient Subgroups by Baseline High/Low Lp(a), LDL-C…
Phase 2 data highlight consistent and sustained reductions in Intraocular Pressure (IOP), statistically significant (p<0.0001)…
